knowledge -WSS

knowledge

author：leisure time 2025-09-27 12:35:49 - browse：252

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Medicare Advantage today, explained in one chart

focus

WSS

Google says AlphaFold 3 can map a vast universe of biomolecules

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Study: People of West African ancestry at greater risk of cardiac amyloidosis

EU regulator recommends expanding Mounjaro approval to obesity

What nurses really want: sufficient staffing for patient care

Apple Watch's A

hotspot

knowledge

hotspot

Bright Health sells Medicare Advantage business to Molina

Eli Lilly, Pfizer, and others want in on the online prescription market

Continuity nursing helped my family in our darkest PICU moments

Independent physicians launch a new lobbying group

Trump demands the U.S. pay no more for drugs than other countries … again

FDA clears AI tool for detecting skin cancer

Wildfire smoke exposes gaps in outdoor worker protections

Medicare says breakthrough device reimbursement rule to come by summer

New air purifier tech could be key to improving indoor air quality

H5N1 communication has been strictly for the birds

hotspot

Researchers on aging grapple with how to calculate biological age

Parkinson’s finding may lead to tests and, someday, treatments

After gene therapy, two congenitally deaf children hear for the first time

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Why doctors need education on FDA device approval process

EU regulator recommends expanding Mounjaro approval to obesity

knowledge

focus

focus

entertainment